<HashMap><database>bioimages</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Meredith E.K. Calvert</submitter><journal>The Journal of Cell Biology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-JCBD-201101055</full_dataset_link><attach_to>JCB</attach_to><legend>A Z-stack of optical sections from a representative hypha during actomyosin ring constriction, showing the localization of Lifeact-GFP (green), FM4-64 (red), and calcofluor (blue) to label actin, cell membrane and cell wall, respectively. See also Supplemental Video 3.</legend><legend>Time-lapse imaging shows the decrease in ring diameter over time within a representative hypha expressing Lifeact-GFP (green) and membranes labeled with FM4-64 (red). &lt;br /></legend><legend>A Z-stack of optical sections showing adjacent actomyosin rings immediately following the photobleaching of Myo-2-GFP (green). The ring on the right has been bleached. See also Supplemental Video 4.</legend><legend>Time-lapse imaging shows that the actin binding probe Lifeact-GFP accumulated along the hyphal cortex, assembled into a contractile ring, and persisted at the ring throughout septation.  See also Supplemental video 2.</legend><legend>Time-lapse imaging shows the decrease in ring diameter over time within a representative hypha expressing Myo2-GFP (green) and membranes labeled with FM4-64 (red). See also Supplemental Video 1.</legend><legend>Time-lapse imaging shows the decrease in ring diameter over time within a representative hypha expressing Lifeact-GFP (green) and membranes labeled with FM4-64 (red).</legend><legend>Single image showing Lifeact-GFP (green) and membranes labeled with FM4-64 (red) following inhibition of actin polymerization with 10 um Latrunculin A.</legend><legend>Delocalization of Myo-2-GFP (green) from the ring and stalled membrane closure (FM4-64, red) following treatement with 1mM blebbistatin</legend><legend>Time-lapse of Z-stacks of optical sections showing adjacent actomyosin rings during fluorescence recovery after photobleaching (FRAP) of Myo2-GFP (green). The ring on the right has been bleached. See also Supplemental Video 4.</legend><legend>Time-lapse imaging shows Lifeact-GFP (green) and membranes labeled with FM4-64 (red) following treatment with DMSO.</legend><legend>Time-lapse imaging shows the decrease in ring diameter over time within a representative hypha expressing Myo2-GFP (green) and membranes labeled with FM4-64 (red).</legend><legend>A Z-stack of optical sections showing adjacent actomyosin rings prior to the photobleaching of Myo-2-GFP (green). See also Supplemental Video 4.&lt;br /></legend><legend>Time-lapse imaging of Myo2-GFP (green) and membranes labeled with FM4-64 (red) following treatment with MeOH. See also Supplemental Video 4.</legend><legend>Time-lapse of Z-stacks of optical sections from a representative hypha during actomyosin ring constriction, showing the localization of Lifeact-GFP (green), FM4-64 (red), and calcofluor (blue) to label actin, cell membrane and cell wall, respectively. See also Supplemental Video 3.</legend><repository>bioimages</repository><figure_sub>Image 30437 (Figure 3 - A)</figure_sub><figure_sub>Image 30436 (Figure 2 - E)</figure_sub><figure_sub>Figure 8 - A</figure_sub><figure_sub>Image 131134 (Figure 7 - C)</figure_sub><figure_sub>Image 30439 (Figure 3 - B)</figure_sub><figure_sub>Figure 7 - A</figure_sub><figure_sub>Figure 7 - C</figure_sub><figure_sub>Image 30442 (Figure 7 - C)</figure_sub><figure_sub>Figure 3 - A</figure_sub><figure_sub>Figure 3 - B</figure_sub><figure_sub>Image 30441 (Figure 3 - C)</figure_sub><figure_sub>Figure 3 - C</figure_sub><figure_sub>Image 30438 (Figure 3 - B)</figure_sub><figure_sub>Image 131129 (Figure 7 - A)</figure_sub><figure_sub>Image 30440 (Figure 3 - C)</figure_sub><figure_sub>Image 131131 (Figure 7 - A)</figure_sub><figure_sub>Image 131128 (Figure 7 - A)</figure_sub><figure_sub>Image 131109 (Figure 2 - D)</figure_sub><figure_sub>Image 30445 (Figure 8 - A)</figure_sub><figure_sub>Figure 2 - E</figure_sub><figure_sub>Figure 7</figure_sub><figure_sub>Figure 8</figure_sub><figure_sub>Image 131133 (Figure 8 - A)</figure_sub><figure_sub>Figure 2 - D</figure_sub><figure_sub>Figure 3</figure_sub><figure_sub>Figure 2</figure_sub><pubmed_authors>Fong Yew Leong</pubmed_authors><pubmed_authors>Mohan K. Balasubramanian</pubmed_authors><pubmed_authors>Yinxiao Chen</pubmed_authors><pubmed_authors>Meredith E.K. Calvert</pubmed_authors><pubmed_authors>Gregory Jedd</pubmed_authors><pubmed_authors>Keng-Hwee Chiam</pubmed_authors><pubmed_authors>Graham D. Wright</pubmed_authors></additional><is_claimable>false</is_claimable><name>Myosin concentration underlies cell size–dependent scalability of actomyosin ring constriction</name><description/><dates><release>2011-11-28T11:21:59Z</release><modification>2018-11-29T11:21:59Z</modification><creation>2018-11-29T11:21:59Z</creation></dates><accession>S-JCBD-201101055</accession><cross_references><doi>10.1083/jcb.201101055</doi></cross_references></HashMap>